Works matching AU Fotiou, Despina

Results: 94
    1

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    2
    3
    4

    Daratumumab May Attenuate Cardiac Dysfunction Related to Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma: A Prospective Study.

    Published in:
    Cancers, 2021, v. 13, n. 20, p. 5057, doi. 10.3390/cancers13205057
    By:
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Makris, Nikolaos;
    • Georgiopoulos, Georgios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Laina, Ageliki;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Delialis, Dimitris;
    • Andreadou, Ioanna;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    5

    Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.

    Published in:
    Cancers, 2021, v. 13, n. 17, p. 4480, doi. 10.3390/cancers13174480
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Giatra, Chara;
    • Asimakopoulos, Ioannis;
    • Dimou, Maria;
    • Sklirou, Aimilia D.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Darmani, Ismini;
    • Briasoulis, Alexandros;
    • Kastritis, Efstathios;
    • Angelopoulou, Maria;
    • Baltadakis, Ioannis;
    • Panayiotidis, Panayiotis;
    • Trougakos, Ioannis P.;
    • Vassilakopoulos, Theodoros P.;
    • Pagoni, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    6

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    7

    Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3245, doi. 10.3390/cancers12113245
    By:
    • Papadimitriou, Konstantinos;
    • Tsakirakis, Nikolaos;
    • Malandrakis, Panagiotis;
    • Vitsos, Panagiotis;
    • Metousis, Andreas;
    • Orologas-Stavrou, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Pothos, Panagiotis;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania E.;
    • Kostopoulos, Ioannis V.
    Publication type:
    Article
    8
    9

    Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00802-0
    By:
    • Moscvin, Maria;
    • Liacos, Christine Ivy;
    • Chen, Tianzeng;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Hossain, Shahrier;
    • Rowell, Sean;
    • Leblebjian, Houry;
    • Regan, Eileen;
    • Czarnecki, Peter;
    • Bagnoli, Filippo;
    • Bolli, Niccolo';
    • Richardson, Paul;
    • Rennke, Helmut G.;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios;
    • Bianchi, Giada
    Publication type:
    Article
    10

    Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00802-0
    By:
    • Moscvin, Maria;
    • Liacos, Christine Ivy;
    • Chen, Tianzeng;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Hossain, Shahrier;
    • Rowell, Sean;
    • Leblebjian, Houry;
    • Regan, Eileen;
    • Czarnecki, Peter;
    • Bagnoli, Filippo;
    • Bolli, Niccolo’;
    • Richardson, Paul;
    • Rennke, Helmut G.;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios;
    • Bianchi, Giada
    Publication type:
    Article
    11

    The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00530-3
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    12

    Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00381-4
    By:
    • Fotiou, Despina;
    • Roussou, Maria;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Dialoupi, Ioanna;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Giannouli, Stavroula;
    • Delavinia, Christina;
    • Efstathiou, Kostantinos;
    • Kontogiannis, Sofoklis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    13

    The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 9, p. N.PAG, doi. 10.1038/s41408-020-00360-9
    By:
    • Gavriatopoulou, Maria;
    • Βoultadaki, Andriani;
    • Koutoulidis, Vassilis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Bourgioti, Charis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Moulopoulos, Lia-Angela
    Publication type:
    Article
    14

    Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

    Published in:
    2020
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papatheodorou, Athanasios;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Kokkali, Nikoletta-Aikaterini;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Letter
    15

    Patterns of target organ amyloid deposition in patients with AL amyloidosis; role for diagnosis and prognosis.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 6, p. 1212, doi. 10.1080/10428194.2023.2197537
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    16
    17
    18

    Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 3, p. 619, doi. 10.1080/10428194.2018.1509323
    By:
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Koloventzou, Ursula;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Gika, Dimitra;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    19

    Solid Organ Transplantation in Amyloidosis.

    Published in:
    Acta Haematologica, 2020, v. 143, n. 4, p. 352, doi. 10.1159/000508262
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    20

    Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 10, p. 1887, doi. 10.1002/ajh.27414
    By:
    • Kostopoulos, Ioannis V.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Rousakis, Pantelis;
    • Malandrakis, Panagiotis;
    • Panteli, Chrysanthi;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Angelis, Nikolaos;
    • Spiliopoulou, Vasiliki;
    • Syrigou, Rodanthi‐Eleni;
    • Bakouros, Panagiotis;
    • Dimitrakopoulou, Georgia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Paschalidis, Nikolaos;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    21

    Belantamab mafodotin, lenalidomide, and dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin‐associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 3, p. 502, doi. 10.1002/ajh.27219
    By:
    • Gavriatopoulou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Psarros, Giorgos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    22

    Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. E226, doi. 10.1002/ajh.27001
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Symeonidis, Argiris;
    • Labropoulou, Vasiliki;
    • Delimpasi, Sosana;
    • Mancuso, Katia;
    • Zamagni, Elena;
    • Katodritou, Eirini;
    • Rivolti, Elena;
    • Kyrtsonis, Marie‐Christine;
    • Roussou, Maria;
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Hatjiharissi, Evdoxia;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Cheliotis, Giorgos;
    • Manousou, Kyriaki;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    23
    24

    Chromosome 1q21 aberrations identify ultra high‐risk myeloma with prognostic and clinical implications.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 9, p. 1142, doi. 10.1002/ajh.26639
    By:
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Dalampira, Dimitra;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Sevastoudi, Aggeliki;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Triantafyllou, Theodora;
    • Terpos, Evangelos;
    • Katodritou, Eirini;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    25

    Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. E27, doi. 10.1002/ajh.26406
    By:
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Evangelakou, Zoi;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Manola, Maria S.;
    • Gianniou, Despoina D.;
    • Bagratuni, Tina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    26
    27

    Cell‐free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 6, p. E148, doi. 10.1002/ajh.25802
    By:
    • Ntanasis‐Stathopoulos, Ioannis;
    • Bagratuni, Tina;
    • Gavriatopoulou, Maria;
    • Patseas, Dimitrios;
    • Liacos, Christine;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Tsiligkeridou, Eleni;
    • Andreatou, Amalia;
    • Mavrianou‐Koutsoukou, Nefeli;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    28

    Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 4, p. 400, doi. 10.1002/ajh.25392
    By:
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Christoulas, Dimitrios;
    • Papatheodorou, Athanasios;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Trougakos, Ioannis P.;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    29

    Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 7, p. 632, doi. 10.1002/ajh.24738
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C;
    • Kanellias, Nikos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Giannouli, Stavroula;
    • Psimenou, Erasmia;
    • Marinaki, Smaragdi;
    • Apostolou, Theofanis;
    • Gakiopoulou, Hariklia;
    • Tasidou, Anna;
    • Papassotiriou, Ioannis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    30

    Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00988-x
    By:
    • Kostopoulos, Ioannis V.;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Malandrakis, Panagiotis;
    • Migkou, Magdalini;
    • Angelis, Nikolaos;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Krevvata, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Kastritis, Efstathios
    Publication type:
    Article
    31

    Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 5, p. e310, doi. 10.1016/j.clml.2024.12.017
    By:
    • Fotiou, Despina;
    • Badelita, Sorina Nicoleta;
    • Katodritou, Eirini;
    • Beksac, Meral;
    • Bila, Jelena;
    • Spanoudakis, Emmanouil;
    • Batini&#263, Josip;
    • Coriu, Daniel;
    • Barbu, Sinziana;
    • Danaila, Catalin;
    • Dalampira, Dimitra;
    • Sevastoudi, Angeliki;
    • Seval, Guldane Cengiz;
    • Toprak, Selami Koçak;
    • Sretenovic, Aleksandra;
    • Markovic, Olivera;
    • Valkovic, Toni;
    • Cvetkovic, Zorica;
    • Theodorakakou, Fenia;
    • Gavriatopoulou, Maria
    Publication type:
    Article
    32
    33

    Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
    By:
    • Kastritis, Efstathios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Spiliopoulou, Vassiliki;
    • Gavriatopoulou, Maria;
    • Patel, Sachin;
    • Majer, Istvan;
    • Boukis, Christos;
    • Fetani, Andriani;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    34

    Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 844, doi. 10.1016/j.clml.2023.07.013
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Solia, Eirini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Kokkali, Nikoleta;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Syrigou, Rodanthi;
    • Fotiou, Despina;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    35

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    36

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    37

    MM-408: The Assessment of Stem Cell Graft Contamination via Next-Generation Flow Cytometry Serves as a Negative Predictor for Deep Remissions Post-Autologous Stem Cell Transplantation in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S441, doi. 10.1016/S2152-2650(21)01982-0
    By:
    • Kostopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Panteli, Chrisanthi;
    • Malandrakis, Panagiotis;
    • Kanelias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migou, Magdalini;
    • Liakos, Christina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    38

    Poster: MM-408: The Assessment of Stem Cell Graft Contamination via Next-Generation Flow Cytometry Serves as a Negative Predictor for Deep Remissions Post-Autologous Stem Cell Transplantation in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S253, doi. 10.1016/S2152-2650(21)01584-6
    By:
    • Kostopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Panteli, Chrisanthi;
    • Malandrakis, Panagiotis;
    • Kanelias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migou, Magdalini;
    • Liakos, Christina;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania;
    • Terpos, Evangelos
    Publication type:
    Article
    39

    Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.

    Published in:
    2020
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Gika, Dimitra;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Mparmparousi, Despoina;
    • Gatou, Anastasia;
    • Katopi, Despina;
    • Manios, Efstathios;
    • Liontos, Michail;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    40
    41

    Screening for Gaucher disease in patients with plasma cell dyscrasias.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e327, doi. 10.1016/j.clml.2019.09.537
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    42

    Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e320, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Marinaki, Smaragdi;
    • Psimenou, Erasmia;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Harikleia;
    • Papanota, Aristea-Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    43

    Flow-Mediated Dilatation (FMD) and Aortic Blood Pressure May Predict Cardiovascular Adverse Events During Carfilzomib Therapy: A Prospective Study in Relapsed/Refractory Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.433
    By:
    • Kastritis, Efstathios;
    • Laina, Aggeliki;
    • Gavriatopoulou, Maria;
    • Georgiopoulos, Georgios;
    • Fotiou, Despina;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Makris, Nikolaos;
    • Papanota, Aristea-Maria;
    • Trougakos, Ioannis P.;
    • Kotsopoulou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    44

    Longitudinal Evaluation of Minimal Residual Disease in Patients with Multiple Myeloma who Achieve Complete Response After First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e185, doi. 10.1016/j.clml.2019.09.310
    By:
    • Kostopoulos, Ioannis V.;
    • Kastritis, Efstathios;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    45

    Absence of Aberrant Plasma Cells in the Apheresis Product Predicts for Minimal Residual Disease Negativity after Autologous Transplantation in Myeloma Patients Who Receive First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e184, doi. 10.1016/j.clml.2019.09.309
    By:
    • Terpos, Evangelos;
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    46

    Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S331, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Dialoupi, Ioanna;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papadopoulou, Elektra;
    • Ziogas, Dimitrios C.;
    • Stamatelopoulos, Kimon;
    • Manios, Efstathios;
    • Ntalianis, Argyrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Migkou, Magdalini;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Tselegkidi, Marini;
    • Tsitsilonis, Ourania;
    • Trougakos, Ioannis
    Publication type:
    Article
    47

    Derivation of Prediction Model for Treatment Failure Risk in Multiple Myeloma Patients Based on Biomarkers of Hypercoagulability. The Prospective Observational ROADMAP-MM-CAT Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S323, doi. 10.1016/j.clml.2019.07.306
    By:
    • Gerotziafas, Grigoris;
    • Fotiou, Despina;
    • Sergentanis, Theodoros;
    • Papageorgiou, Loula;
    • Rousseau, Aurelie;
    • Van Dreden, Patrick;
    • Elalamy, Ismail;
    • Larsen, Annette;
    • Falanga, Anna;
    • Terpos, Evangelos;
    • Mohty, Mohamad;
    • Dimopoulos, Meletios
    Publication type:
    Article
    48

    Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly Diagnosed Chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. The Observational ROADMAT-CAT-MM Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S235, doi. 10.1016/j.clml.2018.07.121
    By:
    • Fotiou, Despina;
    • Sergentanis, Theodoros;
    • Papageorgiou, Loula;
    • Gavriatopoulou, Maria;
    • Psaltopoulou, Theodora;
    • VanDreden, Patrick;
    • Larsen, Annette;
    • Elalamy, Ismail;
    • Kastritis, Efstathios;
    • Stamatelopoulos, Kimon;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios;
    • Gerotziafas, Grigoris
    Publication type:
    Article
    49

    Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.114
    By:
    • Dimopoulos, Meletios Athanasios;
    • Pouli, Anastasia;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Psimenou, Erasmia;
    • Matsouka, Charis;
    • Mparmparousi, Despoina;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    50